Earnings call: Rhythm Pharmaceuticals reports 'transformative year', eyes 2025

Published on 23 Feb 2024 on Investing.com

Rhythm Pharmaceuticals, Inc. (NASDAQ: NASDAQ: RYTM ) discussed its fourth quarter and full year 2023...

Read the rest of the article

Start tracking your investments with Statfolio

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is possibly approaching a major achievement in its bus...

Simply Wall St. via Yahoo Finance 14 Apr 2024

Joseph Shulman, Chief Technical Officer of Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), has sold 18,...

GuruFocus.com via Yahoo Finance 22 Mar 2024

Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), a biopharmaceutical company focused on the development ...

GuruFocus.com via Yahoo Finance 20 Mar 2024

Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), a biopharmaceutical company focused on the development ...

GuruFocus.com via Yahoo Finance 20 Mar 2024

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Chief Financial Officer Hunter C. Smith has sold a tot...

Investing.com 19 Mar 2024

This particular sale was aimed at covering withholding taxes associated with the vesting of certa...

Investing.com 19 Mar 2024

Shareholders might have noticed that Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) filed its yearly ...

Simply Wall St. via Yahoo Finance 24 Feb 2024

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript February 22, 2024 Rhy...

Insider Monkey via Yahoo Finance 23 Feb 2024

Rhythm Pharmaceuticals, Inc. (NASDAQ: NASDAQ: RYTM ) discussed its fourth quarter and full year 2...

Investing.com 23 Feb 2024

Investing.com 22 Feb 2024